Strides starts exports of generic version of Avigan for COVID-19 treatment
Antiviral drug has been developed in-house with API manufacturer signed up to secure KSM
Strides Pharma Science has developed and started exporting a generic version of Fujifilm’s flu antiviral Avigan (favipiravir), which has shown promise in treating patients with COVID-19, the Indian pharma company said on Wednesday.
Strides said it has begun shipment of tablets in 400mg and 200mg doses to three unnamed Gulf Cooperation Council countries to treat patients under their COVID-19 treatment programme, making it the first Indian company to begin exports of the medicine.
The drug is being manufactured at Strides’ main facility in Bangalore, India, which can produce up to 6 billion units of solid orals per year.
To boost supply, Strides has also entered into a preferred arrangement with an Indian active pharmaceutical ingredient (API) manufacturer with capabilities to manufacture the favipiravir API from its key starting material in-house.
In a statement, Strides CEO Dr R Ananthanarayanan, said favipiravir had already demonstrated positive outcomes in several studies on COVID-19 patients.
“Favipiravir is a complex drug to make, while we are manufacturing the tablets in-house, we are also excited to partner with the API manufacturer such that our supply chain remains secured up to the key starting material,” he added.
Strides said it would immediately apply to Indian drug regulatory authorities to begin necessary studies and make the drug available domestically.
In February, following the novel coronavirus outbreak, favipiravir was studied in China and several other countries as an experimental treatment for COVID-19 and demonstrated a reduction in the duration of the disease and improved lung conditions in patients.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance